drugset / Trial / NCT06840925
A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628
RandomizedCrossoverOpen-labelTreatment
Summary
A phase I clinical trial to evaluate the relative bioavailability of PRAX-628 tablet formulation compared to capsule formulation
Timeline
- Start
- 2025-03-24
- Primary completion
- 2025-05-30
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRAX-628 | Unknown | 40 mg | Oral |
Indications
No indication recorded.